Recent Finacing
Recent Raise
Axio Biosolutions develops patented chitosan‑based hemostatic and biomaterial wound‑care products (Axiostat, MaxioCel), operates from Boston and Bengaluru, and markets FDA‑ and CE‑cleared devices in 40+ countries.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
